Therefore, a more in‐depth study of the molecular mechanism underlying the effects of UBE2S in HCC and the role of UBE2S in sorafenib sensitivity in HCC is extremely meaningful. This evidence concerns the gene UBE2S and hepatocellular carcinoma.